AI-driven systems designed to detect and forecast the next pandemic.

The rapid rise of AI-driven systems is designed to detect and forecast zoonotic spillover, especially as climate change, land use shifts, and global mobility increase the frequency of animal-to-human transmission. Researchers are building models that integrate wildlife surveillance, ecological data, viral genomics, and environmental change indicators to identify hotspots where pathogens are most likely to jump species.

However, the data gaps remain the biggest barrier. Wildlife disease surveillance is sparse, fragmented, and geographically uneven. Many regions with high spillover risk lack systematic sampling, and existing datasets are often incompatible or incomplete. AI models can highlight risk zones, but their predictive power depends heavily on the quality and continuity of underlying data.

AI will not “prevent” pandemics on its own — but it can significantly improve early warning systems, guide targeted surveillance, and help governments and global health organizations allocate resources more effectively.

The global diagnostics landscape is shifting. As climate change accelerates ecological disruption and zoonotic spillover becomes more frequent, AI-powered surveillance systems are emerging as one of the most important tools for anticipating infectious threats before they reach clinical settings.

A recent Nature article highlights how researchers are building models that combine wildlife sampling, ecological mapping, viral genomics, and environmental change data to identify where the next spillover event is most likely to occur. For the diagnostics industry, this represents a strategic inflection point.

Why AI-Based Spillover Prediction Matters for IVD.

Diagnostics companies increasingly operate in a world where speed, adaptability, and early situational awareness determine competitive advantage. AI-driven spillover forecasting can reshape how the industry prepares for emerging pathogens:

• Earlier assay development windows: If AI models flag high-risk regions or species months before human cases appear, assay developers can begin preemptive R&D, accelerating time to market for molecular and antigen tests.

• More targeted surveillance testing public health agencies and private labs can deploy portable PCR, isothermal amplification platforms, and syndromic panels to areas flagged as high risk, improving detection sensitivity and reducing blind spots.

• Better resource allocation for point-of-care diagnostics: Predictive modeling helps governments and NGOs determine where rapid tests, mobile labs, and decentralized diagnostic systems will be most needed during early outbreak phases.

The Limiting Factor: Data Quality

The article underscores a critical challenge: wildlife surveillance data is inconsistent, incomplete, and geographically biased. For diagnostics manufacturers, this reinforces the need to:

• Advocate for standardized global sampling frameworks.

• Support partnerships with ecological researchers and genomic surveillance networks.

• Invest in data-ready assay platforms that can rapidly incorporate new targets.

AI can only be as strong as the data feeding it — and the diagnostics industry has a vested interest in strengthening that pipeline.

Strategic Outlook for Diagnostics Leaders

At GRN IVD Consulting, we see AI-driven spillover prediction as a catalyst for:

1. Earlier market intelligence on emerging pathogens.

2. Faster assay prototyping cycles.

3. New competitive differentiation for companies that integrate ecological and genomic forecasting into their product roadmaps.

4. Expansion of decentralized testing models, especially in high-risk geographies.

The future of outbreak-ready diagnostics will be shaped not only by laboratory innovation, but by predictive intelligence systems that illuminate threats before they reach the clinic. AI-powered zoonotic surveillance is becoming a foundational layer of global health security — and a strategic priority for diagnostics companies preparing for the next wave of infectious disease challenges.

Citation: Nature — “AI models are being used to track zoonotic diseases. Will they prevent the next pandemic?” (2026).